Eczema Vaccinatum Patients Needed
Have you ever had Eczema Vaccinatum?
Eczema vaccinatum is a life
threatening reaction to smallpox vaccine. Currently, people with
active atopic dermatitis (eczema) or people who have had atopic
dermatitis in the past, and the people they live with can not receive
smallpox vaccinations. This is because of the risk of eczema
vaccinatum (EV).
About The Eczema Vaccinatum Study
In 1972, U.S. health care providers stopped routinely
administering the smallpox vaccine because the world was free of the
disease and because of possible risks from the smallpox vaccine itself.
Today, however, the possibility exists that an outbreak of smallpox
could be caused by a bioterrorist act, which might make smallpox
vaccinations necessary again.
The Atopic Dermatitis and Vaccinia Network (ADVN) is a
consortium of academic medical centers that are conducting studies to
find ways to make smallpox vaccinations safer for people with atopic dermatitis (AD).
The ADVN needs people who have ever had eczema vaccinatum. We are seeking individuals 1-80 years old who have atopic dermatitis and who have ever had a widespread herpes virus infection (eczema herpeticum) and/or eczema vaccinatum.
To find out more about the study, please call 1-888-413-5852, contact the ADVN site nearest you, or send an e-mail to LairsmithJ@njhealth.org.
Financial compensation is available for qualified participants as well as travel money to an ADVN site.
ADVN sites are:
PI: Donald Leung, MD, PhD, 303-398-1067
PI: Jon Hanifin, 503-494-2121
PIs: Rich Gallo, MD, PhD and Tissa Hata, MD, 858-657-8390
PI: Lynda Schneider, MD, 617-355-6127
PIs: Robert Wood, MD and Kathleen Barnes, PhD, 410-614-5467
PI: Lisa Beck, MD, 585-275-0374
Sponsored by the National Institute of Allergy and
Infectious Diseases, National Institutes of Health, Department of
Health and Human Services, Contract # HHSN266200400029C
